GKOS News and Press, Glaukos Corporation

2026-02-17 23:15:46 ET More on Glaukos Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript Glaukos Corporation (GKOS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Glaukos Corporation (GKOS) Presents at Citi Annual Global Healthcare Con...

2026-02-17 23:14:57 ET Glaukos Corporation (GKOS) Q4 2025 Earnings Call February 17, 2026 4:30 PM EST Company Participants Christopher Lewis - Vice President of Investor Relations & Corporate Affairs Thomas Burns - Chairman & CEO Joseph Gilliam - President ...

2026-02-17 18:30:33 ET Image source: The Motley Fool. Feb. 17, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-17 16:10:55 ET More on Glaukos Glaukos Corporation (GKOS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Glaukos Corporation (GKOS) Presents at Citi Annual Global Healthcare Conference 2025 Transcript Glaukos Q4 2025 Earnings Preview ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial results for the fourth quarter and full year ended December 31, 2025. Key high...

Iamgold Corporation (IAG) is expected to report $0.55 for Q4 2025 Bel Fuse Inc (BELFB) is expected to report $1.44 for Q4 2025 Beta Bionics Inc. (BBNX) is expected to report $-0.42 for Q4 2025 TPG RE Finance Trust Inc. (TRTX) is expected to report $0.25 for Q4 2025 CEVA Inc. (CEVA...

2026-02-15 17:35:00 ET More on Glaukos Glaukos Corporation (GKOS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Glaukos Corporation (GKOS) Presents at Citi Annual Global Healthcare Conference 2025 Transcript Glaukos rises as FDA greenlights lab...

2026-02-03 10:00:00 ET The following segment was excerpted from Alger Weatherbie Specialized Growth Fund ( AWSAX ) Q4 2025 Commentary ... Read the full article on Seeking Alpha For further details see: Alg...

2026-01-29 22:30:00 ET The following segment was excerpted from the Harbor Small Cap Growth Fund ( HASGX ) Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance

2026-01-28 13:04:40 ET from BTIG issued a price target of $131.00 for GKOS on 2026-01-28 17:18:16. The adjusted price target was set to $131.00. At the time of the announcement, GKOS was trading at $125.46. The overall price target consensus is at $139.10 with high price...